Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Int Urol Nephrol ; 54(12): 3139-3144, 2022 Dec.
Article in English | MEDLINE | ID: mdl-35951254

ABSTRACT

PURPOSE: The incidence of urethral recurrence (UR) following radical cystectomy (RC) for transitional cell carcinoma (TCC) of the bladder varies between 1.5 and 6%. There is debate over the timing of urethrectomy for patients undergoing RC. We evaluated the requirement for a formal surveillance programme for UR in patients after RC. METHODS: We retrospectively reviewed the outcomes of patients who underwent RC between 2006 and 2019. Females, non-TCC cases and patients with neo-bladder diversions were excluded. Histological prostatic urethral involvement at the time of RC was deemed high risk for UR. Carcinoma in-situ, multifocal tumours and bladder neck involvement were deemed intermediate risk and the absence of the above features was considered low risk. RESULTS: 417 patients underwent RC, 300 cases remained after exclusion criteria were applied. 42 patients were high-risk for UR, 102 patients were intermediate risk and 156 were low risk. Of the 300, 24 urethrectomy cases were recorded. Six cases of UR occurred. Of these, 5 presented with symptoms and only 1 case was detected by surveillance. Only 1 low-risk patient developed UR, 7 years post RC. Using our risk stratification, UR rates for high, intermediate and low-risk cohorts were 25%, 10.5% and 0.8%, respectively. CONCLUSIONS: In our cohort, routine surveillance for all patients with annual urethroscopy was of limited value in detecting UR post RC. Staged Urethrectomy for high and intermediate-risk patients, and patient counselling in self-identification of recurrence symptoms for low-risk patients will improve the early detection of UR.


Subject(s)
Carcinoma, Transitional Cell , Urethral Neoplasms , Urinary Bladder Neoplasms , Female , Humans , Cystectomy , Retrospective Studies , Urinary Bladder/surgery , Urinary Bladder/pathology , Urinary Bladder Neoplasms/surgery , Urinary Bladder Neoplasms/pathology , Neoplasm Recurrence, Local/pathology , Carcinoma, Transitional Cell/surgery , Carcinoma, Transitional Cell/pathology , Cohort Studies , Urethral Neoplasms/diagnosis , Urethral Neoplasms/surgery , Urethral Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL